Definium’s stock jumps 55% following impressive results from LSD-based depression medication
Definium Therapeutics’ Stock Surge On Monday, Definium Therapeutics saw its stock price jump by 50%, reaching its highest point in over four years. This spike followed the announcement of promising results from a late-stage trial involving their experimental drug, which is based on LSD. The drug reportedly led to a significant reduction in major depression […]